Ask anything about Basalog One Pre Filled Pen Injection
Overview
Drug | Injection
Uses & Benefits
Diabetes mellitus (Type 1 and Type 2) for basal (long-acting) glycaemic control; used alone or with other antidiabetic medicines/insulin
How It Works
Insulin glargine is a long-acting insulin analogue. After subcutaneous injection it forms microprecipitates that slowly release insulin, providing a steady basal insulin level to lower blood glucose throughout the day and night.
Frequently Asked Questions
What is this medicine used for?
Diabetes mellitus (Type 1 and Type 2) for basal (long-acting) glycaemic control; used alone or with other antidiabetic medicines/insulin
What are the side effects?
Hypoglycaemia, injection site reactions (pain, redness, swelling, itching), lipodystrophy, weight gain, oedema, rash, allergic reactions
How does this medicine work?
Insulin glargine is a long-acting insulin analogue. After subcutaneous injection it forms microprecipitates that slowly release insulin, providing a steady basal insulin level to lower blood glucose throughout the day and night.
How should I use this medicine?
For subcutaneous use only. Inject once daily at the same time each day as advised by the doctor into abdomen, thigh or upper arm; rotate injection sites. Can be taken with or without food. Do not mix or dilute with other insulins; do not use intravenously or in an insulin pump. Prime the pen before each injection and use a new needle each time.
How should I store this medicine?
Unopened pens: store in a refrigerator at 2–8°C; do not freeze; keep away from freezer compartment and protect from light. In-use pen: keep at room temperature (generally below 25–30°C as per pack instructions) away from heat and light; discard after the in-use period stated on the label (commonly 28 days). Do not store with needle attached.
Disclaimer
Product information is for awareness only and does not replace medical advice. Do not self-medicate for serious symptoms. For Rx medicines, a valid prescription is required. Consult your doctor or pharmacist for personalized guidance.
Sources: Manufacturer labeling/prescribing information, CDSCO/drug label requirements, established medical literature (insulin glargine monographs), standard clinical guidelines for diabetes
Availability depends on stock and serviceability.
Directions for Use
For subcutaneous use only. Inject once daily at the same time each day as advised by the doctor into abdomen, thigh or upper arm; rotate injection sites. Can be taken with or without food. Do not mix or dilute with other insulins; do not use intravenously or in an insulin pump. Prime the pen before each injection and use a new needle each time.
Side Effects
Hypoglycaemia, injection site reactions (pain, redness, swelling, itching), lipodystrophy, weight gain, oedema, rash, allergic reactions
Warnings & Precautions
Risk of hypoglycaemia—monitor blood glucose and carry fast-acting sugar. Do not use for diabetic ketoacidosis (DKA). Dose adjustment may be needed with changes in diet, activity, illness, renal/hepatic impairment, or when switching insulins. Avoid injecting into areas of lipodystrophy; rotate sites. Seek urgent care for severe allergy, repeated hypoglycaemia, confusion, or loss of consciousness.
Drug Interactions
Other antidiabetics (sulfonylureas, meglitinides) increase hypoglycaemia risk, beta-blockers may mask hypoglycaemia symptoms, corticosteroids/thyroid hormones/diuretics/sympathomimetics may raise glucose and reduce insulin effect, ACE inhibitors and salicylates may enhance glucose-lowering, alcohol can increase risk of hypoglycaemia, pioglitazone with insulin may increase risk of fluid retention/heart failure
Storage Instructions
Unopened pens: store in a refrigerator at 2–8°C; do not freeze; keep away from freezer compartment and protect from light. In-use pen: keep at room temperature (generally below 25–30°C as per pack instructions) away from heat and light; discard after the in-use period stated on the label (commonly 28 days). Do not store with needle attached.
